Colin C Anderson Selected Research

Zineb

1/2021

Maneb alters central carbon metabolism and thiol redox status in a toxicant model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin C Anderson Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 06/2007
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2006
4	Neuroblastoma 01/2021 - 01/2018
3	Down Syndrome (Down's Syndrome) 01/2021 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2018
3	Lymphopenia (Lymphocytopenia) 01/2018 - 01/2017
2	Infections 01/2022 - 01/2011
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Hypercholesterolemia 01/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020
1	Necrosis 01/2020
1	Bronchiolitis Obliterans Syndrome 12/2019
1	Melanoma (Melanoma, Malignant) 12/2019
1	Proteostasis Deficiencies 02/2019
1	Starvation 01/2019
1	Cicatrix (Scar) 12/2015
1	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2015
1	Human Influenza (Influenza) 07/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011
1	Leukemia 01/2011
1	Lymphoma (Lymphomas) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2006

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2021 - 01/2006
2	ManebIBA 01/2021 - 01/2018
2	CarbonIBA 01/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 05/2020 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2020
2	Simvastatin (Zocor)FDA LinkGeneric 01/2020 - 01/2020
2	CytokinesIBA 01/2018 - 01/2017
2	Peptides (Polypeptides)IBA 01/2018 - 01/2017
1	ZinebIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	nabamIBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	EicosanoidsIBA 01/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	IsotopesIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	CaspasesIBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020
1	Apelin ReceptorsIBA 01/2020
1	IpilimumabIBA 12/2019
1	Free RadicalsIBA 02/2019
1	Proteins (Proteins, Gene)FDA Link 02/2019
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2019
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 01/2019
1	SNARE Proteins (SNAREs)IBA 01/2019
1	ParaquatIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2015
1	Hemagglutinins (Hemagglutinin)IBA 07/2014
1	EpitopesIBA 07/2014
1	AutoantigensIBA 07/2014
1	Monoclonal AntibodiesIBA 01/2011
1	Histocompatibility Antigens Class IIBA 06/2007
1	CD40 Ligand (CD40L)IBA 01/2006
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2006
1	AntigensIBA 01/2006

Therapy/Procedure

5	Immunotherapy 05/2020 - 06/2007
4	Therapeutics 01/2022 - 07/2009
2	Islets of Langerhans Transplantation 04/2006 - 01/2006
1	Cell Transplantation 01/2022
1	Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2019
1	Hematopoietic Stem Cell Transplantation 01/2011